NCT04456088View on ClinicalTrials.gov

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 15, 2020

Primary Completion Date

November 15, 2020

Study Completion Date

December 15, 2020

Conditions
COVID-19SARS-CoV 2Respiratory DiseasePneumonia, ViralCorona Virus Infection
Interventions
COMBINATION_PRODUCT

150 ppm Nitric Oxide delivered through LungFit Delivery System

Nitric Oxide delivered via LungFit system. Patients will receive inhalations of 150 ppm for 40 minutes 4 time per day plus standard supportive care.

COMBINATION_PRODUCT

80 ppm Nitric Oxide delivered through LungFit Delivery System

Nitric Oxide delivered via LungFit system. Patients will receive inhalations of 80 ppm for 40 minutes 4 time per day plus standard supportive care.

Sponsors

Lead Sponsor

Beyond Air Inc.
All Listed Sponsors
lead

Beyond Air Inc.

INDUSTRY